Max Reed

Dr. Max Reed

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OGOlivia Erline Gilbert
Olivia Erline Gilbert
HFHenry Forbes Fowler
Henry Forbes Fowler
AMAsish Madarapu
Asish Madarapu
MRMax Reed
Max Reed
AFAli Fahim
Ali Fahim
DHDominique M. O. Higgins
Dominique M. O. Higgins
Glioblastoma (GBM) remains the most common and most aggressive primary malignant brain tumor in adults, and despite maximal safe resection with adjuvant radiotherapy (RT) and temozolomide (TMZ), median overall survival remains 12–15 months with near-universal recurrence. Ferroptosis, an iron-dependent form of regulated cell death driven by the accumulation of lipid peroxides, has emerged as a distinctive vulnerability in GBM, whose iron-avid phenotype, polyunsaturated fatty acid-rich milieu, and high oxygen consumption create a permissive substrate for lipid peroxidation. In this review, we synthesize preclinical evidence positioning ferroptosis as a determinant of GBM radiosensitivity and evaluate strategies to exploit it. We first outline core ferroptosis biology and GBM-specific modifiers of ferroptotic susceptibility, including TFR1-mediated iron import, grade-dependent glutathione peroxidase 4 (GPX4) expression, acyl-coenzyme A synthetase long-chain family member 4 (ACSL4) levels, transsulfuration, NRF2, p53, non-coding RNAs, and the relative resistance of mesenchymal tumors and glioma stem cells. We then examine mechanisms of radiation-induced ferroptosis, in which RT upregulates ACSL4 and depletes glutathione (GSH) while simultaneously provoking adaptive responses that induce the cystine transporter solute carrier family 7 member 11 (SLC7A11) and GPX4, alongside hypoxia-, IFI16/HMOX1-, and lncRNA-mediated programs that sustain radioresistance, noting that recurrent tumors display a ferroptosis-primed profile after chemoradiation. Radiosensitization strategies are reviewed across pharmacologic ferroptosis inducers (classes I-IV), repurposed agents, NRF2 inhibition, genetic targeting of ferroptosis mediators, and blood–brain barrier-penetrant nanoplatforms that couple iron delivery, high-Z radiation deposition, and antioxidant disruption. We further address the immunologic consequences of ferroptosis within the immunosuppressive GBM microenvironment, the countervailing problem of radiation-induced brain injury and candidate neuroprotective approaches, the potential convergence of FLASH RT with iron-dependent differential sparing, and comparative evidence of ferroptosis-RT synergy in other treatment-resistant malignancies. Finally, we appraise candidate biomarkers and ferroptosis-related gene signatures, and close by addressing open questions and current translational hurdles facing the field.

22 December 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PNParsa Nilchian
Parsa Nilchian
MRMax Reed
Max Reed
AYAndrew B. Yang
Andrew B. Yang
GKGary Kocharian
Gary Kocharian
KFKai-Ming Fu
Kai-Ming Fu
BACKGROUND: Extramedullary plasmacytomas (EMPs) are rare plasma cell tumors forming outside the bone marrow. EMPs spread to soft tissues with a predilection for the head and neck region. Therefore, EMPs are rarely included in the differential for peripheral nerve sheath tumors (PNSTs). The authors discuss a case of tibial nerve sheath invasion by an EMP in the context of multiple myeloma (MM). OBSERVATIONS: A 70-year-old female with MM presented with right leg pain and a suspected PNST of the tibial nerve. Imaging revealed a T1-hypointense lesion in the popliteal fossa. Resection was attempted, but frozen pathology revealed a plasma cell neoplasm with a high Ki-67 proliferation rate. The resection was halted due to the tumor’s infiltrative and hemorrhagic nature and its extensive encasement of the tibial nerve. Postoperatively, the patient received 5 fractions of radiation therapy and three courses of teclistamab, which she continued as an outpatient without complications. LESSONS: This case highlights a rare occurrence of peripheral nerve invasion by an EMP with the first documented involvement of the tibial nerve. This report suggests that EMPs should be considered in the differential diagnosis of PNSTs, particularly in MM patients. The present case underscores the need for intraoperative biopsies in PNST resection, as imaging features alone may not be fully diagnostic. https://thejns.org/doi/10.3171/CASE25104